Dr. Youssef Kousa is a neonatal neurologist and scientist who has been at the forefront of developing synergistic teams in studying emerging pathogens and translating these insights into therapeutic targets. Dr. Kousa is the Founding Director of the Prenatal Infection and Neurodevelopmental Genetics (PING) Consortium. Formed nearly a decade ago, the PING consortium is an international clinical and translational research effort designed to identify maternal and prenatal factors affecting virally induced brain injury, develop diagnostic platforms, and advance therapeutic protocols. With investments by NIH and CDC, the PING Consortium includes six countries, 19 cities, 23 centers, 35 researchers, nearly 8,000 mother/infant participants, and 3063 bio-banked samples. The team is systematically gathering and maintaining volumes of clinical, laboratory, imaging, developmental, and genomic data. The datasets are currently being used to identify modifiers of epidemic viral infections and brain injury.
Dr. Kousa is also the founding principal investigator of the K-Labs research program, a discovery-oriented basic research effort using cell, tissue culture, and animal systems to study emerging viral infections and test therapeutic targets. Expertise in the lab includes neurology, pediatrics, neurobiology, virology, bioinformatics, genomics, immunology, vaccine development and RNA therapeutics.